Higher TIM-3 levels are observed in most advanced stages of gastric cancer [129], and high levels of TIM-3 expression on NK cells correlated with reduced overall survival in oesophageal cancer, melanoma, hepatocellular carcinoma and lung adenocarcinoma [127,133,134,135]. This evidence concerns the gene HAVCR2 and lung adenocarcinoma.